U.S. Trial Finds CRISPR-Edited Cells Are Safe in Cancer Patients
For years, scientists have hoped to use the gene-editing technology CRISPR to help treat all sorts of diseases, including cancer. Now for the first time in the U.S., researchers say they've shown that CRISPR-edited immune cells can be safely given to cancer patients and survive for up to nine months-a finding that"